Pandite LN - Search Results

1

Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinoma.

Xu CF, Reck BH, Goodman VL, Xue Z, Huang L, Barnes MR, Koshy B, Spraggs CF, Mooser VE, Cardon LR, Pandite LN. Xu CF, et al. Among authors: pandite ln. J Hepatol. 2011 Jun;54(6):1237-43. doi: 10.1016/j.jhep.2010.09.028. Epub 2011 Feb 12. J Hepatol. 2011. PMID: 21145803 Clinical Trial.

2

Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma.

Hutson TE, Davis ID, Machiels JP, De Souza PL, Rottey S, Hong BF, Epstein RJ, Baker KL, McCann L, Crofts T, Pandite L, Figlin RA. Hutson TE, et al. J Clin Oncol. 2010 Jan 20;28(3):475-80. doi: 10.1200/JCO.2008.21.6994. Epub 2009 Dec 14. J Clin Oncol. 2010. PMID: 20008644 Clinical Trial.

3

Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.

Xu CF, Reck BH, Xue Z, Huang L, Baker KL, Chen M, Chen EP, Ellens HE, Mooser VE, Cardon LR, Spraggs CF, Pandite L. Xu CF, et al. Br J Cancer. 2010 Apr 27;102(9):1371-7. doi: 10.1038/sj.bjc.6605653. Epub 2010 Apr 13. Br J Cancer. 2010. PMID: 20389299 Free PMC article.

4

Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes.

Xu CF, Bing NX, Ball HA, Rajagopalan D, Sternberg CN, Hutson TE, de Souza P, Xue ZG, McCann L, King KS, Ragone LJ, Whittaker JC, Spraggs CF, Cardon LR, Mooser VE, Pandite LN. Xu CF, et al. Among authors: pandite ln. J Clin Oncol. 2011 Jun 20;29(18):2557-64. doi: 10.1200/JCO.2010.32.9110. Epub 2011 May 16. J Clin Oncol. 2011. PMID: 21576632

5

Concomitant use of pazopanib and simvastatin increases the risk of transaminase elevations in patients with cancer.

Xu CF, Xue Z, Bing N, King KS, McCann LA, de Souza PL, Goodman VL, Spraggs CF, Mooser VE, Pandite LN. Xu CF, et al. Among authors: pandite ln. Ann Oncol. 2012 Sep;23(9):2470-2471. doi: 10.1093/annonc/mds249. Ann Oncol. 2012. PMID: 22918879 Free article. No abstract available.

6

A randomized and open-label trial evaluating the addition of pazopanib to lapatinib as first-line therapy in patients with HER2-positive advanced breast cancer.

Johnston SR, Gómez H, Stemmer SM, Richie M, Durante M, Pandite L, Goodman V, Slamon D. Johnston SR, et al. Breast Cancer Res Treat. 2013 Feb;137(3):755-66. doi: 10.1007/s10549-012-2399-4. Epub 2013 Jan 3. Breast Cancer Res Treat. 2013. PMID: 23283526 Clinical Trial.

7

Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms.

Motzer RJ, Johnson T, Choueiri TK, Deen KC, Xue Z, Pandite LN, Carpenter C, Xu CF. Motzer RJ, et al. Among authors: pandite ln. Ann Oncol. 2013 Nov;24(11):2927-8. doi: 10.1093/annonc/mdt394. Epub 2013 Oct 9. Ann Oncol. 2013. PMID: 24107802 Free PMC article. No abstract available.

8

Identification of a variant in KDR associated with serum VEGFR2 and pharmacodynamics of Pazopanib.

Maitland ML, Xu CF, Cheng YC, Kistner-Griffin E, Ryan KA, Karrison TG, Das S, Torgerson D, Gamazon ER, Thomeas V, Levine MR, Wilson PA, Bing N, Liu Y, Cardon LR, Pandite LN, O'Connell JR, Cox NJ, Mitchell BD, Ratain MJ, Shuldiner AR. Maitland ML, et al. Among authors: pandite ln. Clin Cancer Res. 2015 Jan 15;21(2):365-72. doi: 10.1158/1078-0432.CCR-14-1683. Epub 2014 Nov 19. Clin Cancer Res. 2015. PMID: 25411163 Free PMC article.

9

IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma.

Xu CF, Johnson T, Garcia-Donas J, Choueiri TK, Sternberg CN, Davis ID, Bing N, Deen KC, Xue Z, McCann L, Esteban E, Whittaker JC, Spraggs CF, Rodríguez-Antona C, Pandite LN, Motzer RJ. Xu CF, et al. Among authors: pandite ln. Br J Cancer. 2015 Mar 31;112(7):1190-8. doi: 10.1038/bjc.2015.64. Br J Cancer. 2015. PMID: 25695485 Free PMC article.

10

HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer.

Xu CF, Johnson T, Wang X, Carpenter C, Graves AP, Warren L, Xue Z, King KS, Fraser DJ, Stinnett S, Briley LP, Mitrica I, Spraggs CF, Nelson MR, Tada H, du Bois A, Powles T, Kaplowitz N, Pandite LN. Xu CF, et al. Among authors: pandite ln. Clin Cancer Res. 2016 Mar 15;22(6):1371-7. doi: 10.1158/1078-0432.CCR-15-2044. Epub 2015 Nov 6. Clin Cancer Res. 2016. PMID: 26546620 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters